Bartels CM, Chodara A, Chen Y, et al. - In this study, adjusted 30-day readmission and mortality were compared among systemic lupus erythematosus (SLE), heart failure (HF), and general Medicare to assess predictors informing readmission prevention. Researchers conducted a database study to use a 20% sample of all US Medicare 2014 adult hospitalizations to match the risk of 30-day readmission and mortality among admissions with SLE, HF, and neither per discharge diagnoses (if both SLE and HF, classified as SLE). In this analysis, SLE admissions (n=10,868) were younger, predominantly female, more likely to be Black, disabled, and have Medicaid or end-stage renal disease (ESRD). It has been reported that 30-day SLE readmissions rivaled HF at 24%. This study’s findings demonstrate that readmission prevention programs should engage young, ESRD patients with SLE and examine potential causal gaps in SLE care and transitions.